| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |